Cubist Systematic Strategies, LLC Nautilus Biotechnology, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.13 $6,030 - $9,631	3,077 Added 24.62%	15,577 $33,000
Q2 2022 Aug 15, 2022	SELL	$2.64 - $4.84 $38,781 - $71,099	-14,690 Reduced 54.03%	12,500 $34,000
Q1 2022 May 16, 2022	SELL	$3.5 - $5.3 $149,604 - $226,543	-42,744 Reduced 61.12%	27,190 $118,000
Q4 2021 Feb 14, 2022	SELL	$4.45 - $6.21 $20,234 - $28,236	-4,547 Reduced 6.1%	69,934 $362,000
Q3 2021 Nov 15, 2021	BUY	$6.14 - $10.1 $440,428 - $724,483	71,731 Added 2608.4%	74,481 $457,000
Q2 2021 Aug 16, 2021	BUY	$9.04 - $14.19 $24,859 - $39,022	2,750 New	2,750 $28,000

64.3M

1.9K

100

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $299M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.